This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm.
The latest data is out on Pradaxa bleeding events and the numbers are nothing short of downright terrifying.
Pradaxa manufacturer Boehringer Ingelheim just put online on “pradaxa.de” some new data on fatal/major bleeds as reported to the company up to end of 2013.
It is shocking to see that despite decreasing Pradaxa prescriptions still, about 60 patients die every month from a Pradaxa bleed.
New Pradaxa Bleeding Data
Green figures are calculated and can be compared with data released by the Institute for Safe Medication Practices:
|
|
31. March 2013 | 30. June 2013 | 30. Sept 2013 | 31. Dec 2013 |
| Fatal bleeds | 1.163 | 1.448 | 1.637 | 1.646 |
| Majors bleeds (include fatal) | 7.601 | 9.138 | 9.939 | 10.798 |
| Major bleeds (nonfatal) | 6.438 | 7.690 | 8.302 | 9.152 |
| fatal bleeds as % of major bleeds | 18 | 19 | 20 | 18 |
The only logical conclusion is that the high case fatality of a major bleed with Pradaxa support the hypothesis that the irreversible nature of Pradaxa is responsible for the catastrophic outcome following a bleeding event.
If you or a loved one was prescribed Pradaxa and suffered a bleeding event, contact The Michael Brady Lynch Firm for a no-cost, no-obligation review of your case.